These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 8623929)

  • 1. Induction of Heymann nephritis with a gp330/megalin fusion protein.
    Raychowdhury R; Zheng G; Brown D; McCluskey RT
    Am J Pathol; 1996 May; 148(5):1613-23. PubMed ID: 8623929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of two forms of GP330. Their role in Heymann nephritis.
    Bachinsky DR; Zheng G; Niles JL; McLaughlin M; Abbate M; Andres G; Brown D; McCluskey RT
    Am J Pathol; 1993 Aug; 143(2):598-611. PubMed ID: 8342605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Megalin (gp330) possesses an antigenic epitope capable of inducing passive Heymann nephritis independent of the nephritogenic epitope in receptor-associated protein.
    Orlando RA; Kerjaschki D; Farquhar MG
    J Am Soc Nephrol; 1995 Jul; 6(1):61-7. PubMed ID: 7579071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of receptor-associated 39/45 kD protein in active Heymann nephritis.
    Huang J; Makker SP
    Kidney Int; 1995 Feb; 47(2):432-41. PubMed ID: 7723231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Heymann nephritis antigenic complex: megalin (gp330) and RAP.
    Farquhar MG; Saito A; Kerjaschki D; Orlando RA
    J Am Soc Nephrol; 1995 Jul; 6(1):35-47. PubMed ID: 7579068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A major pathogenic antigen of Heymann nephritis is present exclusively in the renal proximal tubule brush border--studies with a monoclonal antibody against pronase-digested tubular antigen.
    Tsukada Y; Ono K; Maezawa A; Yano S; Naruse T
    Clin Exp Immunol; 1994 May; 96(2):303-10. PubMed ID: 8187338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. All four putative ligand-binding domains in megalin contain pathogenic epitopes capable of inducing passive Heymann nephritis.
    Yamazaki H; Ullrich R; Exner M; Saito A; Orlando RA; Kerjaschki D; Farquhar MG
    J Am Soc Nephrol; 1998 Sep; 9(9):1638-44. PubMed ID: 9727372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular cloning of a cDNA encoding a major pathogenic domain of the Heymann nephritis antigen gp330.
    Pietromonaco S; Kerjaschki D; Binder S; Ullrich R; Farquhar MG
    Proc Natl Acad Sci U S A; 1990 Mar; 87(5):1811-5. PubMed ID: 2408041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of a 330-kDa glycoprotein from human kidney similar to the Heymann nephritis autoantigen (gp330).
    Kanalas JJ; Makker SP
    J Am Soc Nephrol; 1990 Nov; 1(5):792-8. PubMed ID: 2133428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells: possible role in the pathogenesis of Heymann glomerulonephritis.
    Camussi G; Brentjens JR; Noble B; Kerjaschki D; Malavasi F; Roholt OA; Farquhar MG; Andres G
    J Immunol; 1985 Oct; 135(4):2409-16. PubMed ID: 3875653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of passive Heymann nephritis with antibodies specific for a synthetic peptide derived from the receptor-associated protein.
    Kerjaschki D; Ullrich R; Exner M; Orlando RA; Farquhar MG
    J Exp Med; 1996 May; 183(5):2007-15. PubMed ID: 8642311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis - implications for the pathogenesis of idiopathic human membranous glomerulonephritis.
    Makker SP; Tramontano A
    J Pathol; 2006 Nov; 210(3):282-7. PubMed ID: 16981232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A small N-terminal 60-kD fragment of gp600 (megalin), the major autoantigen of active Heymann nephritis, can induce a full-blown disease.
    Oleinikov AV; Feliz BJ; Makker SP
    J Am Soc Nephrol; 2000 Jan; 11(1):57-64. PubMed ID: 10616840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.
    Susani M; Schulze M; Exner M; Kerjaschki D
    Am J Pathol; 1994 Apr; 144(4):807-19. PubMed ID: 8160779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunocytochemical and biochemical characterization of the Heymann nephritis antigenic complex in rat L2 yolk sac cells.
    Lundstrom M; Orlando RA; Saedi MS; Woodward L; Kurihara H; Farquhar MG
    Am J Pathol; 1993 Nov; 143(5):1423-35. PubMed ID: 8238258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats.
    Kerjaschki D; Farquhar MG
    J Exp Med; 1983 Feb; 157(2):667-86. PubMed ID: 6337231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epitope specificity of anti-gp330 autoantibodies determines the development of proteinuria in active Heymann nephritis.
    Van Leer EH; Ronco P; Verroust P; van der Wal AM; Hoedemaeker PJ; De Heer E
    Am J Pathol; 1993 Mar; 142(3):821-9. PubMed ID: 7681258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of glomeruli-eluted Gp330 autoantibodies and of Gp330 antigen of Heymann nephritis.
    Makker SP
    J Immunol; 1993 Dec; 151(11):6500-8. PubMed ID: 8245481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenic antibodies inhibit the binding of apolipoproteins to megalin/gp330 in passive Heymann nephritis.
    Kerjaschki D; Exner M; Ullrich R; Susani M; Curtiss LK; Witztum JL; Farquhar MG; Orlando RA
    J Clin Invest; 1997 Nov; 100(9):2303-9. PubMed ID: 9410908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel autoantibody to plasminogen and its characterization in Heymann nephritis.
    Makker SP
    Clin Immunol Immunopathol; 1994 Jul; 72(1):105-13. PubMed ID: 8020183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.